4757
-
Vascular Health and Risk Management
-
Dr Pérez-López (Logout)
My Dovepress
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(1,472,206) Views
Editor in Chief Professor Roland Asmar
Society News: ISVH – A multi-disciplinary society ||FREE PAPER||Roland Asmar
Erratum
Sexual function in hypertensive patients receiving treatment
Thorsten Reffelmann, Robert A Kloner
The impact of health literacy on cardiovascular disease
Richard S Safeer, Catherine E Cooke, Jann Keenan
Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano Lara Fernandes, Antônio Eduardo Pesaro, Carlos V Serrano Jr
Outcomes of coronary artery bypass graft surgery
Anna Louise Hawkes, Madeleine Nowak, Benjamin Bidstrup, Richard Speare
Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects
Liliana Legedz, Giampiero Bricca, Pierre Lantelme, Marie-Odile Rial, Pierre Champomier, Madeleine Vincent, Hugues Milon
Assessment of cognitive function in patients with essential hypertension treated with lercanidipine
J Tisaire-Sánchez, J Roma, Ignacio Camacho-Azcargorta, J Bueno-Gómez, J Mora-Maciá, Angel Navarro
Hypothyroidism in coronary heart disease and its relation to selected risk factors
Otto Mayer Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, Richard Pikner
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level
Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk and Prevention Study
Olmesartan medoxomil: current status of its use in monotherapy
Hans R Brunner
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
Claudio Borghi, Arrigo FG Cicero
Management of cancer-associated venous thrombosis
Ozlem Er, Leo Zacharski
Bivalirudin in percutaneous coronary intervention
Sam J Lehman, Derek P Chew
Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
David Bergqvist
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
Alexander GG Turpie
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)
Huyen Tran, Shamir R Mehta, John W Eikelboom
A review of levosimendan in the treatment of heart failure
Hulya Akhan Kasikcioglu, Nese Cam
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
Mark Greathouse
Sildenafil in the treatment of pulmonary hypertension
Christopher F Barnett, Roberto F Machado
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
Melvin R Echols, Clyde W Yancy
Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
Heng Joo Ng, Lai Heng Lee
Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
JV (Ian) Nixon
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
